Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Income Statement
Earnings Waterfall
Biomarin Pharmaceutical Inc
Revenue
|
2.5B
USD
|
Cost of Revenue
|
-513.5m
USD
|
Gross Profit
|
2B
USD
|
Operating Expenses
|
-1.8B
USD
|
Operating Income
|
177.3m
USD
|
Other Expenses
|
28.2m
USD
|
Net Income
|
205.4m
USD
|
Income Statement
Biomarin Pharmaceutical Inc
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
572
N/A
|
627
+10%
|
667
+6%
|
749
+12%
|
801
+7%
|
860
+7%
|
892
+4%
|
890
0%
|
924
+4%
|
974
+5%
|
1 045
+7%
|
1 117
+7%
|
1 184
+6%
|
1 201
+1%
|
1 255
+5%
|
1 314
+5%
|
1 383
+5%
|
1 439
+4%
|
1 496
+4%
|
1 491
0%
|
1 518
+2%
|
1 533
+1%
|
1 603
+5%
|
1 704
+6%
|
1 805
+6%
|
1 847
+2%
|
1 863
+1%
|
1 861
0%
|
1 844
-1%
|
1 917
+4%
|
1 849
-4%
|
1 846
0%
|
1 880
+2%
|
1 912
+2%
|
2 008
+5%
|
2 096
+4%
|
2 173
+4%
|
2 235
+3%
|
2 311
+3%
|
2 419
+5%
|
2 472
+2%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(98)
|
(107)
|
(109)
|
(122)
|
(130)
|
(137)
|
(144)
|
(152)
|
(161)
|
(174)
|
(188)
|
(210)
|
(216)
|
(221)
|
(230)
|
(242)
|
(274)
|
(297)
|
(316)
|
(315)
|
(322)
|
(321)
|
(339)
|
(360)
|
(382)
|
(402)
|
(494)
|
(524)
|
(533)
|
(562)
|
(477)
|
(471)
|
(467)
|
(463)
|
(476)
|
(484)
|
(493)
|
(498)
|
(507)
|
(515)
|
(513)
|
|
Gross Profit |
474
N/A
|
520
+10%
|
558
+7%
|
627
+12%
|
671
+7%
|
722
+8%
|
748
+4%
|
738
-1%
|
763
+3%
|
800
+5%
|
857
+7%
|
907
+6%
|
967
+7%
|
980
+1%
|
1 025
+5%
|
1 072
+5%
|
1 109
+3%
|
1 142
+3%
|
1 180
+3%
|
1 176
0%
|
1 196
+2%
|
1 213
+1%
|
1 264
+4%
|
1 345
+6%
|
1 424
+6%
|
1 445
+1%
|
1 369
-5%
|
1 336
-2%
|
1 311
-2%
|
1 355
+3%
|
1 372
+1%
|
1 376
+0%
|
1 412
+3%
|
1 448
+3%
|
1 532
+6%
|
1 612
+5%
|
1 680
+4%
|
1 736
+3%
|
1 804
+4%
|
1 904
+6%
|
1 958
+3%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(618)
|
(664)
|
(713)
|
(795)
|
(886)
|
(981)
|
(1 027)
|
(1 023)
|
(878)
|
(997)
|
(1 033)
|
(1 108)
|
(1 715)
|
(1 199)
|
(1 200)
|
(1 222)
|
(1 159)
|
(1 324)
|
(1 363)
|
(1 355)
|
(1 340)
|
(1 410)
|
(1 438)
|
(1 465)
|
(1 451)
|
(1 460)
|
(1 449)
|
(1 433)
|
(1 428)
|
(1 418)
|
(1 433)
|
(1 460)
|
(1 490)
|
(1 499)
|
(1 532)
|
(1 548)
|
(1 608)
|
(1 645)
|
(1 685)
|
(1 746)
|
(1 781)
|
|
Selling, General & Administrative |
(242)
|
(260)
|
(278)
|
(310)
|
(351)
|
(382)
|
(397)
|
(406)
|
(404)
|
(414)
|
(440)
|
(473)
|
(496)
|
(536)
|
(549)
|
(565)
|
(583)
|
(594)
|
(611)
|
(610)
|
(639)
|
(638)
|
(657)
|
(676)
|
(708)
|
(725)
|
(740)
|
(738)
|
(721)
|
(728)
|
(728)
|
(761)
|
(780)
|
(792)
|
(826)
|
(831)
|
(882)
|
(901)
|
(908)
|
(937)
|
(940)
|
|
Research & Development |
(357)
|
(379)
|
(417)
|
(462)
|
(518)
|
(568)
|
(601)
|
(635)
|
(652)
|
(661)
|
(663)
|
(662)
|
(648)
|
(624)
|
(617)
|
(611)
|
(650)
|
(682)
|
(690)
|
(696)
|
(696)
|
(706)
|
(718)
|
(715)
|
(674)
|
(670)
|
(644)
|
(628)
|
(635)
|
(614)
|
(624)
|
(629)
|
(641)
|
(638)
|
(638)
|
(650)
|
(661)
|
(680)
|
(713)
|
(747)
|
(780)
|
|
Depreciation & Amortization |
(15)
|
(15)
|
(15)
|
(11)
|
(13)
|
(14)
|
(14)
|
(11)
|
(19)
|
(24)
|
(31)
|
(30)
|
(30)
|
(30)
|
(30)
|
(36)
|
(36)
|
(36)
|
(36)
|
(30)
|
(30)
|
(36)
|
(45)
|
(54)
|
(62)
|
(64)
|
(63)
|
(62)
|
(62)
|
(62)
|
(62)
|
(62)
|
(62)
|
(62)
|
(63)
|
(63)
|
(63)
|
(63)
|
(47)
|
(62)
|
(45)
|
|
Other Operating Expenses |
(4)
|
(11)
|
(4)
|
(13)
|
(5)
|
(17)
|
(16)
|
29
|
197
|
102
|
101
|
57
|
(541)
|
(9)
|
(3)
|
(10)
|
110
|
(11)
|
(26)
|
(19)
|
25
|
(29)
|
(19)
|
(21)
|
(8)
|
(1)
|
(2)
|
(5)
|
(10)
|
(15)
|
(19)
|
(8)
|
(8)
|
(6)
|
(6)
|
(4)
|
(2)
|
(2)
|
(16)
|
0
|
(16)
|
|
Operating Income |
(144)
N/A
|
(144)
0%
|
(155)
-8%
|
(168)
-8%
|
(215)
-28%
|
(259)
-20%
|
(280)
-8%
|
(285)
-2%
|
(115)
+60%
|
(197)
-72%
|
(177)
+10%
|
(201)
-14%
|
(747)
-272%
|
(219)
+71%
|
(174)
+20%
|
(151)
+14%
|
(50)
+67%
|
(182)
-267%
|
(183)
-1%
|
(179)
+2%
|
(143)
+20%
|
(197)
-37%
|
(174)
+12%
|
(120)
+31%
|
(28)
+77%
|
(15)
+47%
|
(80)
-445%
|
(96)
-20%
|
(117)
-21%
|
(64)
+45%
|
(61)
+4%
|
(84)
-37%
|
(78)
+7%
|
(51)
+35%
|
0
N/A
|
65
+32 200%
|
72
+11%
|
91
+28%
|
119
+31%
|
158
+32%
|
177
+12%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(18)
|
(25)
|
(28)
|
(24)
|
(17)
|
(20)
|
(25)
|
(31)
|
(45)
|
(43)
|
(41)
|
(36)
|
(27)
|
(20)
|
(17)
|
(18)
|
(17)
|
(16)
|
(16)
|
(16)
|
(6)
|
(8)
|
(3)
|
(7)
|
(1)
|
(1)
|
(4)
|
(13)
|
(14)
|
(9)
|
(5)
|
(3)
|
(4)
|
(6)
|
(4)
|
2
|
12
|
23
|
34
|
41
|
49
|
|
Non-Reccuring Items |
(6)
|
(6)
|
64
|
67
|
67
|
67
|
(0)
|
171
|
0
|
(428)
|
(428)
|
(599)
|
0
|
0
|
0
|
125
|
0
|
145
|
145
|
50
|
0
|
45
|
45
|
25
|
85
|
70
|
70
|
60
|
0
|
0
|
0
|
0
|
108
|
108
|
108
|
85
|
0
|
0
|
0
|
(25)
|
(2)
|
|
Total Other Income |
1
|
1
|
1
|
0
|
0
|
(9)
|
(9)
|
(9)
|
(9)
|
(2)
|
0
|
5
|
8
|
10
|
9
|
8
|
4
|
7
|
9
|
2
|
4
|
2
|
3
|
7
|
4
|
6
|
3
|
7
|
10
|
9
|
17
|
12
|
10
|
5
|
(4)
|
(2)
|
(12)
|
(6)
|
(2)
|
14
|
13
|
|
Pre-Tax Income |
(167)
N/A
|
(174)
-4%
|
(119)
+32%
|
(125)
-5%
|
(165)
-32%
|
(220)
-33%
|
(313)
-43%
|
(155)
+51%
|
(169)
-9%
|
(669)
-296%
|
(646)
+4%
|
(831)
-29%
|
(766)
+8%
|
(229)
+70%
|
(183)
+20%
|
(36)
+80%
|
(62)
-74%
|
(46)
+26%
|
(45)
+3%
|
(143)
-219%
|
(145)
-2%
|
(158)
-9%
|
(128)
+19%
|
(95)
+26%
|
60
N/A
|
59
-1%
|
(12)
N/A
|
(42)
-255%
|
(121)
-185%
|
(64)
+47%
|
(49)
+23%
|
(75)
-54%
|
36
N/A
|
56
+58%
|
101
+79%
|
150
+49%
|
72
-52%
|
108
+50%
|
152
+40%
|
189
+24%
|
237
+26%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(8)
|
(13)
|
(8)
|
(9)
|
2
|
8
|
3
|
(17)
|
(18)
|
145
|
175
|
201
|
215
|
60
|
38
|
(39)
|
(45)
|
(41)
|
(42)
|
66
|
60
|
52
|
91
|
71
|
55
|
63
|
63
|
47
|
53
|
39
|
3
|
7
|
(0)
|
(6)
|
(21)
|
(8)
|
(1)
|
(8)
|
(5)
|
(21)
|
(32)
|
|
Income from Continuing Operations |
(175)
|
(187)
|
(126)
|
(134)
|
(163)
|
(212)
|
(310)
|
(172)
|
(187)
|
(524)
|
(471)
|
(630)
|
(551)
|
(169)
|
(144)
|
(75)
|
(107)
|
(87)
|
(87)
|
(77)
|
(85)
|
(106)
|
(38)
|
(24)
|
114
|
122
|
51
|
5
|
(67)
|
(25)
|
(46)
|
(68)
|
35
|
50
|
80
|
142
|
72
|
100
|
147
|
168
|
205
|
|
Net Income (Common) |
(175)
N/A
|
(187)
-7%
|
(126)
+32%
|
(134)
-6%
|
(163)
-22%
|
(212)
-30%
|
(310)
-46%
|
(172)
+45%
|
(187)
-9%
|
(524)
-180%
|
(471)
+10%
|
(630)
-34%
|
(551)
+13%
|
(169)
+69%
|
(144)
+15%
|
(117)
+19%
|
(145)
-24%
|
(125)
+14%
|
(125)
0%
|
(77)
+38%
|
(90)
-16%
|
(110)
-23%
|
(43)
+61%
|
(24)
+44%
|
114
N/A
|
122
+7%
|
852
+597%
|
859
+1%
|
795
-7%
|
837
+5%
|
16
-98%
|
(64)
N/A
|
39
N/A
|
54
+38%
|
84
+55%
|
142
+69%
|
72
-49%
|
100
+39%
|
147
+47%
|
168
+14%
|
205
+23%
|
|
EPS (Diluted) |
-1.22
N/A
|
-1.27
-4%
|
-0.79
+38%
|
-0.92
-16%
|
-1.03
-12%
|
-1.32
-28%
|
-1.92
-45%
|
-1.07
+44%
|
-1.16
-8%
|
-3.23
-178%
|
-2.8
+13%
|
-3.8
-36%
|
-3.19
+16%
|
-0.98
+69%
|
-0.83
+15%
|
-0.67
+19%
|
-0.82
-22%
|
-0.7
+15%
|
-0.7
N/A
|
-0.44
+37%
|
-0.5
-14%
|
-0.61
-22%
|
-0.22
+64%
|
-0.13
+41%
|
0.6
N/A
|
0.67
+12%
|
4.3
+542%
|
4.48
+4%
|
4.31
-4%
|
4.51
+5%
|
0.08
-98%
|
-0.37
N/A
|
0.2
N/A
|
0.28
+40%
|
0.45
+61%
|
0.75
+67%
|
0.37
-51%
|
0.51
+38%
|
0.76
+49%
|
0.88
+16%
|
1.03
+17%
|